What is The Prometheus Group?
Headquartered in Dover, New Hampshire, The Prometheus Group operates at the intersection of medical engineering and patient care. The company is a recognized leader in the design, development, and manufacture of sophisticated EMG, Ultrasound, and Stimulation systems specifically engineered for pelvic health applications. By focusing on this niche yet critical segment of the healthcare market, the firm provides clinicians with the high-precision tools necessary for effective patient diagnostics and rehabilitation. Their product portfolio serves as a cornerstone for practitioners aiming to improve outcomes in pelvic floor dysfunction, positioning the company as an essential provider in the specialized medical technology landscape.
How much funding has The Prometheus Group raised?
The Prometheus Group has raised a total of $421K across 2 funding rounds:
Debt
$150K
Debt
$271K
Debt (2020): $150K with participation from PPP
Debt (2021): $271K led by PPP
Key Investors in The Prometheus Group
PPP
Public-Private Partnership
What's next for The Prometheus Group?
With the successful procurement of late-stage capital, The Prometheus Group is well-positioned to accelerate its research and development initiatives while expanding its commercial footprint. The strategic allocation of these funds will likely focus on enhancing the technological sophistication of their existing ultrasound and stimulation platforms, ensuring compliance with evolving global medical standards. Furthermore, the company is expected to leverage this financial stability to strengthen its supply chain and distribution networks, thereby increasing its market penetration. As the demand for non-invasive pelvic health solutions continues to rise, the firm's ability to maintain its manufacturing excellence will be pivotal in sustaining its competitive advantage and driving long-term enterprise value.
See full The Prometheus Group company page
